leisure time -WSS

leisure time

author：knowledge 2025-10-02 22:39:52 - browse：41

Matts Take Column Illustration — Molly Ferguson for STAT

American medicine is a tragic paradox. An example: Cancer patients are likely dying as a result of drug shortages that occurred partly because generic chemotherapies have been allowed to become too cheap. At the same time, other patients are suffering, and perhaps dying, because the financial burden brought on by the expensive medicines they need is too high.

Sit with that like a terrible Zen koan: Medicines are both too cheap and too expensive.

How is that possible? A lot of it goes back to the 1984 Hatch-Waxman Act, which set up the ecosystem that determines the process by which drugs go from being expensive brands to cheap generics in the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Humana sues Biden admin over Medicare Advantage audit rule

focus

WSS

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Snackable artificial intelligence, expert AI, and the pharma industry

A rare thyroid diagnosis led to unexpected, all

Trump surgeon general acknowledges mistakes during Covid

HIV vaccine remains elusive. Immunologists keep trying new ideas

Second House panel advances two

hotspot

leisure time

entertainment

Virginia high school admissions case could be legal follow

Helping hospitals and community health centers plan for resilience

Medicare details structure of new drug price negotiation program

When prostate cancer spreads, where it goes matters

Wildfire smoke exposes gaps in outdoor worker protections

How to fix cancer clinical trials' diversity problem

Heart attack and stroke risk calculators need revising

The (many) problems with a new study criticizing cancer screening

Walensky prepares to leave CDC — and Congress — behind

Case highlights the risks of experimental stem cell therapy

focus

Data integrity in scientific journals requires "effort" by publishers, institutions

Ethical issues complicate the benefits of medical crowdfunding

HIV vaccine remains elusive. Immunologists keep trying new ideas

'Make People Better': The CRISPR babies story you probably don't know

A rare thyroid diagnosis led to unexpected, all

Cytokinetics CEO stresses company can launch heart drug on its own

focus

focus

focus

hotspot